The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
ESMO Open
; 7(6): 100648, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36462463
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Metformin
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
ESMO Open
Year:
2022
Document type:
Article
Country of publication: